Editors Choice

The FDA approves Aduhelm for the treatment of early Alzheimer's disease. Aduhelm targets brain plaque formation to slow the rate of cognitive decline.

How OMICS and Other Predatory Publishers Enable Scientific Fraudsters

Robert Turner, Founding Editor - December 27, 2020

Predatory Journals like OMICS and Pulsus pose a real danger to the scientific community and public alike.

From AI Excitement to Execution: Why Health Leaders Must Now Master the “How”

Gil Bashe, Medika Life Editor - March 6, 2026

Artificial intelligence is advancing in health care faster than almost any other technology in modern medical history. According to research from McKinsey & Company,...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

Loneliness Is Not Just a Feeling. It’s a Biological Emergency

The Hidden “Friction Tax”

The Same Farm. Two Days. Two Different Worlds

Your Body Is Quietly Eating Its Dead Cells

LATEST

TRENDING

Reiner Fuellmich Fact Checked and Exposed as a Covid Conspiracy Con

Video of Jordon Walker, Supposed Pfizer Researcher, Goes Viral

We Call Out Reiner Fuellmich as a Fraud. The Covid Conspirator Investigated

Pfizer Confirms mRNA Vaccine Never Tested for Preventing COVID Transmission

Fact-Checking Geert Vanden Bossche. Cashing in on Covid Misinformation

Gabor Maté’s Bizarre Ideas on Connections Between Stress and Disease

Worshiping at The Alter of Zach Bush’s Messianic Health Cult

Exposing America’s Frontline Doctors and Their Financial Empire Built on Hydroxychloroquine

Prof Dolores Cahill is the Latest Quack to Commit Career Suicide

Who Not To Trust: A List of 10 Covid-19 Charlatans and “Medical” Snake-Oil Salesmen

EDITORS CHOICE

NBA Bubble Experience Supports Ten Days of Isolation After COVID

FDA Approval of New Drug for Alzheimer’s Offers Hope

How OMICS and Other Predatory Publishers Enable Scientific Fraudsters

From AI Excitement to Execution: Why Health Leaders Must Now Master the “How”

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories